Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Apr 1, 2026
Reporting period
Not applicable
Filed with the SEC
Apr 2, 2026
CEOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000816956-26-000041
Filed / recorded
Apr 2, 2026, 8:05 PM UTC
Added to OQRO
Oct 6, 2026, 10:14 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
CONMED Corp
Issuer CIK
816956
Ticker
CNMD
Reporting person
Pat Beyer
Relationship
Officer
Officer title
President & CEO
Security
RSUs (Restricted Stock Units)
Table
Derivative (Table II)
Transaction date
Apr 1, 2026
Transaction code
A
Shares / units
28,145
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
28,145
Ownership form
Direct
Amendment
No
Footnotes from the filing
On March 23rd, 2026, the CONMED Board of Directors approved an additional equity award for the CEO of $1M in target value to be granted in the form of RSUs and scheduled to vest starting April 1st, 2026 over 3-years in three equal annual tranches with a 2-year post-vest holding period to be applied to net after tax shares after each vesting event.